DiaSorin S.p.A.
DIA
Rang in Aktien
#3778
DiaSorin S.p.A. engages in research and development, manufacture, and... DiaSorin S.p.A. engages in research and development, manufacture, and distribution of immunodiagnostics and molecular diagnostics testing kits in Europe, North America, and internationally. It provides various immunodiagnostic in the areas, including infectious diseases, gastrointestinal diseases, hepatitis and retroviruses, endocrinology, metabolic disorders, tumor markers, and oncology under LIAISON XL and LIAISON XS name. The company also offers Simplexa, a congenital CMV direct kit, which detects cytomegalovirus DNA in saliva swab and urine specimens. In addition, it offers LIAISON PLEX Respiratory Flex Assay and the LIAISON PLEX Yeast Blood Culture Assay. Further, the company offers xMAP technology platform, including in vitro diagnostics. The company was founded in 1968 and is headquartered in Saluggia, Italy.
Aktienkurs
$88.31
Zuletzt synchronisiert: 2026-10-21
Marktkapitalisierung
$4.37B
Veränderung (1 Tag)
-6.35%
Veränderung (1 Jahr)
-2.42%
Land
IT
Handel DiaSorin S.p.A. (DIA)
Kategorie
Healthcare
Kursverlauf für DiaSorin S.p.A. (DIA)
Höchster Schlusskurs: $91.08 am 2026-10-01
Niedrigster Schlusskurs: $16.82 am 2007-07-01
Niedrigster Schlusskurs: $16.82 am 2007-07-01
Kursverlauf der Aktie von DiaSorin S.p.A. von 2007 bis 2026
Jährliche Kursentwicklung
| Jahr | Leistung |
|---|---|
| 2026 (TTM) | 9.72% |
| 2025 | -30.70% |
| 2024 | 7.93% |
| 2023 | -28.26% |
| 2022 | -28.69% |
| 2021 | -5.96% |
| 2020 | 55.52% |
| 2019 | 60.48% |
| 2018 | -9.14% |
| 2017 | 60.80% |
| 2016 | 6.78% |
| 2015 | 29.22% |
| 2014 | -10.91% |
| 2013 | 19.58% |
| 2012 | 46.86% |
| 2011 | -38.72% |
| 2010 | 21.12% |
| 2009 | 94.79% |
| 2008 | -5.47% |
| 2007 | 0.00% |
Aktienkurs vergleichbarer Unternehmen oder Wettbewerber
| Unternehmen | Aktienkurs | Veränderung 1J% | Land |
|---|---|---|---|
| $694.53 | 22.45% |
US
|
|
| $234.00 | 7.29% |
US
|
|
| $416.01 | 121.26% |
US
|
|
| $21.05 | 48.68% |
CN
|
|
| $177.93 | 21.98% |
US
|
